Organization: Health Canada
Year: 2023
Month: May
Request Number: A-2022-001509
Request Summary: The initial cover letter indicating the brand name of the reference drug product and the dosage form of the generic drug in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2023-02-24 for the medicinal ingredients methotrexate & methotrexate sodium. The Screening Acceptance Letter from Health Canada to the generic drug manufacturer confirming completion of screening of the Abbreviated New Drug Submission (ANDS) for methotrexate & methotrexate sodium which appears in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2023-02-24.
Disposition: Disclosed in part
Number of pages: 5